Retinopatía del prematuro: controversias en el uso de antiangiogénicos intraoculares

Ramírez-Ortiz, Marco A.; Lara-Molina, Citlali; Villanueva-García, Dina; Villa-Guillén, Mónica; Jasso-Gutiérrez, Luis; Padilla-Sierra, Leyla Carolina; Robredo-Torres, Violeta; Bravo-Ortiz, Juan Carlos; Gutiérrez Padilla, José Alfonso; Angulo Castellanos, Eusebio; Mancilla Ramírez, Javier; Salgado-Valladares, Manuel Bernardo; Hernández-Peláez, María Graciela; Hernández Salazar, Leonor; Orozco Gómez, Luis Porfirio; Zepeda-Romero, Luz Consuelo.
Bol. méd. Hosp. Infant. Méx ; 70(5): 344-350, sep.-oct. 2013. tab
Artigo em Espanhol | LILACS | ID: lil-702410

Documentos relacionados

  1. [Epidemiological,and physiopathological findings in retinopathy of prematurity: the authors' personal cases].
  2. Eyesight to the Blind-Pharmacotherapy for Retinopathy of Prematurity.
  3. [Long-term Follow-up After Cryocoagulation in Preterm Newborns from Northern Greece with Retinopathy of Prematurity: Three Year Results].
  4. New Aspects on the Treatment of Retinopathy of Prematurity: Currently Available Therapies and Emerging Novel Therapeutics.
  5. [Auditory neuropathy and prematurity: modern view of the issue (literature review)].
  6. [Retinopathy of prematurity: risk factors analysis].
  7. Profissionais de UTI neonatal e alimentação de recém-nascidos com uso do copo
  8. Multimodal assessments of preterm temperament across the first year of life: Continuity, stability, and moderation by country of origin and infant age.
  9. Conocimiento sobre el uso de fármacos off-label en Pediatría. Resultados de una encuesta pediátrica nacional 2012-2013 (estudio OL-PED)
  10. Anti-vascular endothelial growth factor (VEGF) drugs compared to laser photocoagulation for treatment of type 1 retinopathy of prematurity.